- Vitamins and Minerals
- Pre/Probiotic
- Amino Acids
- Glucose
- Lipids
- Omega Fatty Acids
- Others
Clinical Nutrition Market size was valued at USD 40.36 billion in 2022 and is expected to reach USD 57.48 billion in 2029 at a CAGR of 8.6% from 2023-2029. The nutrition of patients in the healthcare industry is referred to as clinical nutrition. Clinical refers to the treatment of outpatients as well as inpatients at clinics and hospitals in this context. Its goal is to help patients maintain a good energy balance while also giving essential nutrients such as protein, vitamins and minerals. Clinical nutrition has several advantages, including its effectiveness in treating type 1 and type 2 diabetes and its ability to help people live better at any age. Outwardly, clinical nutrition items are given to people who are unable to absorb particular nutrients. The market for clinical nutrition is propelling owing to the growing geriatric population who are highly prone to the major health issues related to metabolic disorders & loss of appetite. The increase in initiatives taken by the governments, Malnutrition, rise in junk food intake, poverty, and lack in awareness are the factors that are fuelling the growth of the clinical nutrition market growth. However, strict government regulations, low reimbursement policies, volatility of the market, and patient compliance complexities are the factors hampering the market growth.
Clinical Nutrition Market Key Developments:
- In April 2012, Nestle acquired Pfizer Nutrition to increase its position in infant nutrition market globally In March 2014, Perrigo Company plc and KanPak LLC entered into partnership for manufacturing adult nutritional drinks In April 2016, Perrigo Company plc, launched Glucerna aseptic nutritional shake for diabetic people In July 2017, Perrigo Company plc received U.S. FDA approval of AB-rated ANDA referencing DermOtic Oil Ear Drops.
Global Clinical Nutrition Market Summary
Study Period
2023-29
Base Year
2022
CAGR
8.6%
Largest Market
North America
Fastest Growing Market
Asia Pacific
Clinical Nutrition Market Dynamics
The progressive impact of the growing population pool of baby boomers is protruded to remain as an intermediate in coming years as the expectancy of life is expected to increase due to the improvement of standards of health. The rise in the incidence rate of chronic diseases like diabetes, cancer, and HIV/AIDS is driving the global market growth. In paediatric category, increasing demand for the clinical nutrition is emerged as budding opportunity for market of the clinical nutrition. Growing home care use of nutritional products is anticipated to increase demand for the global market.
Asia Pacific Got Significant Share
Clinical Nutrition Market Regional Analysis
Based on geographical region, the global market is segmented as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. Asia- Pacific is dominating the global market of clinical nutritional products.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The clinical nutrition market report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Global Clinical Nutrition Market Segmentation
By Product Type
By Medical Conditions
- Metabolic Disorders
- Neurological Disorders
- Gastrointestinal Disorders
- Eating Disorders
- Others
By Route of Administration
- Oral
- Enteral
- Parenteral
By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Others
Frequently Asked Questions
The clinical nutrition market is growing at a significant CAGR of 8.6% during the forecast period.
Ajinomoto Co. Inc.,, Perrigo Company Plc, Abbott Nutrition Inc.,, Baxter International Inc., Danon Baby and Medical Nutrition BV,
Asaia Pacific is the fastest-growing region for clinical nutrition market
| 1. Executive Summary |
| 2. Global Clinical Nutrition Market Introduction |
| 2.1. Global Clinical Nutrition Market – Taxonomy |
| 2.2. Global Clinical Nutrition Market –Definitions |
| 2.2.1. By Product Type |
| 2.2.2. By Medical Condition |
| 2.2.3. By Route of Administration |
| 2.2.4. By Distribution Channel |
| 2.2.5. By Region |
| 3. Global Clinical Nutrition Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Global Clinical Nutrition Market Dynamic Factors - Impact Analysis |
| 3.6. Global Clinical Nutrition Market – Competition Landscape |
| 4. Global Clinical Nutrition Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 |
| 4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Global Clinical Nutrition Market, By Product Type, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.1. Vitamins and Minerals |
| 5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) & (Volume, Units) |
| 5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Pre/Probiotics |
| 5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Amino Acids |
| 5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Glucose |
| 5.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 5.5. Lipids |
| 5.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.5.3. Market Opportunity Analysis |
| 5.6. Omega Fatty Acids |
| 5.6.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.6.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.6.3. Market Opportunity Analysis |
| 5.7. Others |
| 5.7.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 5.7.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.7.3. Market Opportunity Analysis |
| 6. Global Clinical Nutrition Market Forecast, By Medical Condition, 2018 - 2022 and Forecast, 2023 - 2029 |
| 6.1. Metabolic Disorders |
| 6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Neurological Disorders |
| 6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Gastrointestinal Disorders |
| 6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Eating Disorders |
| 6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Global Clinical Nutrition Market Forecast, By Route of Administration, 2018 - 2022 and Forecast, 2023 - 2029 |
| 7.1. Oral |
| 7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Enteral |
| 7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Parenteral |
| 7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8. Global Clinical Nutrition Market Forecast, By Distribution Channel, 2018 - 2022 and Forecast, 2023 - 2029 |
| 8.1. Hospital Pharmacies |
| 8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Retail Pharmacies |
| 8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Others |
| 8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 8.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 9. Global Clinical Nutrition Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1. North America |
| 9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.1.3. Market Opportunity Analysis |
| 9.2. Europe |
| 9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.2.3. Market Opportunity Analysis |
| 9.3. Asia-Pacific |
| 9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.3.3. Market Opportunity Analysis |
| 9.4. Latin America |
| 9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.4.3. Market Opportunity Analysis |
| 9.5. Middle East and Africa |
| 9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 9.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 9.5.3. Market Opportunity Analysis |
| 9.6. Global Clinical Nutrition Market - Opportunity Analysis Index, By Product Type, By Medical Condition, By Route of Administration, By Distribution Channel and Country, 2023 - 2029 |
| 10. North America Clinical Nutrition Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 10.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1. Vitamins and Minerals |
| 10.1.2. Pre/Probiotic |
| 10.1.3. Amino Acids |
| 10.1.4. Glucose |
| 10.1.5. Lipids |
| 10.1.6. Omega Fatty Acids |
| 10.1.7. Others |
| 10.2. Medical Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.2.1. Metabolic Disorders |
| 10.2.2. Neurological Disorders |
| 10.2.3. Gastrointestinal Disorders |
| 10.2.4. Eating Disorders |
| 10.2.5. Others |
| 10.3. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.3.1. Oral |
| 10.3.2. Enteral |
| 10.3.3. Parenteral |
| 10.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 10.4.1. Hospital Pharmacies |
| 10.4.2. Retail Pharmacies |
| 10.4.3. Others |
| 10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 10.5.1. U.S. |
| 10.5.2. Canada |
| 10.6. North America Clinical Nutrition Market - Opportunity Analysis Index, By Product Type, By Medical Condition, By Route of Administration, By Distribution Channel and Country, 2023 - 2029 |
| 10.7. North America Clinical Nutrition Market Dynamics – Trends |
| 11. Europe Clinical Nutrition Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 11.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1. Vitamins and Minerals |
| 11.1.2. Pre/Probiotic |
| 11.1.3. Amino Acids |
| 11.1.4. Glucose |
| 11.1.5. Lipids |
| 11.1.6. Omega Fatty Acids |
| 11.1.7. Others |
| 11.2. Medical Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.2.1. Metabolic Disorders |
| 11.2.2. Neurological Disorders |
| 11.2.3. Gastrointestinal Disorders |
| 11.2.4. Eating Disorders |
| 11.2.5. Others |
| 11.3. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.3.1. Oral |
| 11.3.2. Enteral |
| 11.3.3. Parenteral |
| 11.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 11.4.1. Hospital Pharmacies |
| 11.4.2. Retail Pharmacies |
| 11.4.3. Others |
| 11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 11.5.1. Germany |
| 11.5.2. UK |
| 11.5.3. France |
| 11.5.4. Spain |
| 11.5.5. Italy |
| 11.5.6. Russia |
| 11.5.7. Poland |
| 11.5.8. Rest of Europe |
| 11.6. Europe Clinical Nutrition Market - Opportunity Analysis Index, By Product Type, By Medical Condition, By Route of Administration, By Distribution Channel and Country, 2023 - 2029 |
| 11.7. Europe Clinical Nutrition Market Dynamics – Trends |
| 12. Asia-Pacific Clinical Nutrition Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 12.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1. Vitamins and Minerals |
| 12.1.2. Pre/Probiotic |
| 12.1.3. Amino Acids |
| 12.1.4. Glucose |
| 12.1.5. Lipids |
| 12.1.6. Omega Fatty Acids |
| 12.1.7. Others |
| 12.2. Medical Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.2.1. Metabolic Disorders |
| 12.2.2. Neurological Disorders |
| 12.2.3. Gastrointestinal Disorders |
| 12.2.4. Eating Disorders |
| 12.2.5. Others |
| 12.3. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.3.1. Oral |
| 12.3.2. Enteral |
| 12.3.3. Parenteral |
| 12.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 12.4.1. Hospital Pharmacies |
| 12.4.2. Retail Pharmacies |
| 12.4.3. Others |
| 12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 12.5.1. Japan |
| 12.5.2. China |
| 12.5.3. India |
| 12.5.4. ASEAN |
| 12.5.5. Australia & New Zealand |
| 12.5.6. Rest of Asia-Pacific |
| 12.6. Asia-Pacific Clinical Nutrition Market - Opportunity Analysis Index, By Product Type, By Medical Condition, By Route of Administration, By Distribution Channel and Country, 2023 - 2029 |
| 12.7. Asia-Pacific Clinical Nutrition Market Dynamics – Trends |
| 13. Latin America Clinical Nutrition Market Analysis, 2018 - 2022 and Forecast, 2022 – 2028 |
| 13.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1. Vitamins and Minerals |
| 13.1.2. Pre/Probiotic |
| 13.1.3. Amino Acids |
| 13.1.4. Glucose |
| 13.1.5. Lipids |
| 13.1.6. Omega Fatty Acids |
| 13.1.7. Others |
| 13.2. Medical Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.2.1. Metabolic Disorders |
| 13.2.2. Neurological Disorders |
| 13.2.3. Gastrointestinal Disorders |
| 13.2.4. Eating Disorders |
| 13.2.5. Others |
| 13.3. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.3.1. Oral |
| 13.3.2. Enteral |
| 13.3.3. Parenteral |
| 13.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 13.4.1. Hospital Pharmacies |
| 13.4.2. Retail Pharmacies |
| 13.4.3. Others |
| 13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 13.5.1. Brazil |
| 13.5.2. Mexico |
| 13.5.3. Argentina |
| 13.5.4. Rest of Latin America |
| 13.6. Latin America Clinical Nutrition Market - Opportunity Analysis Index, By Product Type, By Medical Condition, By Route of Administration, By Distribution Channel and Country, 2023 - 2029 |
| 13.7. Latin America Clinical Nutrition Market Dynamics – Trends |
| 14. Middle East and Africa Clinical Nutrition Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn) |
| 14.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%), and Market Share (%) |
| 14.1.1. Vitamins and Minerals |
| 14.1.2. Pre/Probiotic |
| 14.1.3. Amino Acids |
| 14.1.4. Glucose |
| 14.1.5. Lipids |
| 14.1.6. Omega Fatty Acids |
| 14.1.7. Others |
| 14.2. Medical Condition Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.2.1. Metabolic Disorders |
| 14.2.2. Neurological Disorders |
| 14.2.3. Gastrointestinal Disorders |
| 14.2.4. Eating Disorders |
| 14.2.5. Others |
| 14.3. Route of Administration Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.3.1. Oral |
| 14.3.2. Enteral |
| 14.3.3. Parenteral |
| 14.4. Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by (Revenue, USD Mn), Y-o-Y Growth (%) and Market Share (%) |
| 14.4.1. Hospital Pharmacies |
| 14.4.2. Retail Pharmacies |
| 14.4.3. Others |
| 14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%) |
| 14.5.1. Gulf Cooperation Council (GCC) Countries |
| 14.5.2. Israel |
| 14.5.3. South Africa |
| 14.5.4. Rest of MEA |
| 14.6. MEA Clinical Nutrition Market - Opportunity Analysis Index, By Product Type, By Medical Condition, By Route of Administration, By Distribution Channel and Country, 2023 - 2029 |
| 14.7. MEA Clinical Nutrition Market Dynamics – Trends |
| 15. Competition Landscape |
| 15.1. Strategic Dashboard of Top Market Players |
| 15.2. Company Profiles (Introduction, Financial Analysis, Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis) |
| 15.2.1. Abbott Nutrition |
| 15.2.2. Nestle Health Science |
| 15.2.3. Baxter Healthcare |
| 15.2.4. B. Braun Melsungen AG |
| 15.2.5. DSM |
| 15.2.6. Danone |
| 15.2.7. Fresenius Kabi AG |
| 15.2.8. Hospira (Pfizer) Inc., |
| 15.2.9. Gentiva Health Services Inc., |
| 15.2.10. Hero Nutritional Inc. |
| 15.2.11. Ajinomoto Co. Inc. |
| 15.2.12. Perrigo Company Plc |
| 16. Research Methodology |
| 17. Key Assumptions and Acronyms |
- Ajinomoto Co. Inc.,
- Perrigo Company Plc
- Abbott Nutrition Inc.,
- Baxter International Inc.,
- Danon Baby and Medical Nutrition BV,
- B. Braun Medical Inc.,
- Fresenius Kabi AG,
- Hospira (Pfizer) Inc.,
- Gentiva Health Services Inc.,
- Hero Nutritional Inc., and
- Nestle SA.